2018: Day 2 Substance Abuse – Lessons learned and where are we going - Presentations

Day 2: Substance Abuse – Lessons learned and where are we going?

Click on presenter's name for link to video or publications.

Note: Some presentations contained unpublished data; therefore, several speakers have provided published manuscripts related to their talks.

John Satterlee, PhD, Program Officer, National Institute on Drug Abuse - Basic Research Funding Opportunities

Day 2 end of day Panel Discussion

Rick Bevins Rick Bevins, PhD
University of Nebraska-Lincoln
Bio-behavioral factors affecting the abuse liability of nicotine
Olivier George Olivier George, PhD
The Scripps Research Institute
Identification of novel targets for cocaine and opioid use disorders using heterogeneous stock rats
Klaus Miczek

Klaus Miczek, PhD
Tufts University
CRF-Dopamine interactions in animal models of social stress and escalated drug abuse

Subhash C. Pandey
Subhash C. Pandey, PhD
University of Illinois at Chicago
Emerging Role of Epigenetic Regulation in Alcohol Use Disorders
Tariq Rana Tariq Rana, PhD
University of California-San Diego Health Sciences
Epigenetic and Epitranscriptomic Regulation of HIV infection
Sabita Roy Sabita Roy, PhD
University of Miami
Microbial dysbiosis observed in Morphine tolerant animals is attenuated in germ free mice and reversed in probiotic treated WT mice
Pietro Sanna Pietro Sanna, MD
The Scripps Research Institute
Stimulant abuse and HIV infection - animal models
Mohan Sopori, PhD  Mohan Sopori, PhD
Lovelace Respiratory Research Institute
Interaction between HIV and cigarette smoke in the development of chronic lung diseases
Minglei Guo Minglei Guo, PhD
University of Nebraska Medical Center 
Role of Microglial activation in cocaine addiction (short talk)
Guoku Hu Guoku Hu, PhD
University of Nebraska Medical Center 
Extracellular vesicle-induced-lincRNA-Cox2 impairs microglial function in opioid users (short talk)

Visit Day 1 NeuroHIV – from bed to bench side for speaker presentations.